Chemoinformaics analysis of 2-Methylbutyl benzoate
| Molecular Weight | 192.258 | nRot | 4 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
| Exact Molecular Weight | 192.115 | nRing | 1 |
| Solubility: LogS | -5.406 | nHRing | 0 |
| Solubility: LogP | 5.609 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 32.3127 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.292 |
| Synth | 2.146 |
| Natural Product Likeliness | 0.758 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.008 |
| HIA | 0.003 |
| CACO-2 | -4.673 |
| MDCK | 0.000018 |
| BBB | 0.994 |
| PPB | 0.910433 |
| VDSS | 0.9 |
| FU | 0.112078 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.731 |
| CYP2c19-sub | 0.09 |
| CYP2c9-inh | 0.5 |
| CYP2c9-sub | 0.926 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.067 |
| CYP3a4-inh | 0.554 |
| CYP3a4-sub | 0.137 |
| CL | 4.277 |
| T12 | 0.679 |
| hERG | 0.009 |
| Ames | 0.003 |
| ROA | 0.03 |
| SkinSen | 0.962 |
| Carcinogencity | 0.594 |
| EI | 0.971 |
| Respiratory | 0.797 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.661128 |